Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Cadbury Report (1)
- China (1)
- City of London (1)
- Corporate governance (1)
- Derivatives (1)
-
- Global financial crisis (1)
- IOSCO (1)
- International capital markets (1)
- International financial standards (1)
- Italy (1)
- Lex mercatoria (1)
- Low-income (1)
- Low-wage jobs (1)
- Oral contracts (1)
- Patient privacy (1)
- Pharmaceutical companies (1)
- Pharmaceutical marketing (1)
- Poverty (1)
- Public health regulation (1)
- Self-regulation (1)
- Stock exchanges (1)
- United Kingdom (1)
- Voluntary codes (1)
- War on poverty (1)
- Welfare (1)
Articles 1 - 4 of 4
Full-Text Articles in Economics
Poverty In America: Why Can't We End It?, Peter B. Edelman
Poverty In America: Why Can't We End It?, Peter B. Edelman
Georgetown Law Faculty Publications and Other Works
The lowest percentage in poverty since we started counting was 11.1 percent in 1973. The rate climbed as high as 15.2 percent in 1983. In 2000, after a spurt of prosperity, it went back down to 11.3 percent, and yet 15 million more people are poor today.
At the same time, we have done a lot that works. From Social Security to food stamps to the earned-income tax credit and on and on, we have enacted programs that now keep 40 million people out of poverty. Poverty would be nearly double what it is now without these measures, according to …
International Financial Standards And The Explanatory Force Of Lex Mercatoria, Cally Jordan
International Financial Standards And The Explanatory Force Of Lex Mercatoria, Cally Jordan
Faculty Papers & Publications
The global financial crisis has cast a strong light on some hitherto obscure corners of the financial world, provoking an outpouring of calls for concerted international action. “Hard law” having disappointed, can “soft law”, in the form of international financial standards, substitute for traditional national legislation. This article examines some of the difficulties associated with the “international standards as soft law” discourse.
First of all, conceptual problems in the “soft law” discourse itself reveal profoundly different patterns of legal thought cutting across national boundaries, resulting in different understandings of international financial standards. Secondly, recent experience, over the past decade, with …
Cadbury Twenty Years On, Cally Jordan
Cadbury Twenty Years On, Cally Jordan
Faculty Papers & Publications
This year marks the twentieth anniversary of the publication of the Cadbury Report, one of the most significant events in modern corporate governance. The Cadbury Report, and its simple two page 'best practices', triggered a global debate on corporate governance. 'Cadbury' codes of corporate governance spread like wildfire. The legacy of the Cadbury Report lives on in the UK with no diminution in the appeal of its voluntary code/comply or explain approach to corporate governance. But there are several clouds looming on the horizon. Comply or explain and voluntary codes of corporate governance appear to have run their course elsewhere …
Marketing Pharmaceuticals: A Constitutional Right To Sell Prescriber-Identified Data?, Lawrence O. Gostin
Marketing Pharmaceuticals: A Constitutional Right To Sell Prescriber-Identified Data?, Lawrence O. Gostin
Georgetown Law Faculty Publications and Other Works
Pharmaceutical companies have strong economic interests in influencing physician-prescribing behaviors. They advertise direct-to-the-consumer and to the physician. Beyond general marketing, manufacturers promote their drugs to physicians through “detailing”—sales representatives (“detailers”) visiting medical offices to persuade physicians to prescribe their products.
By law, pharmacies receive specific information with every prescription, including the physician’s name, the drug, and the dose. Pharmacies sell these records to Prescription Drug Intermediaries (data miners), who use advanced computing to analyze prescriber-identified information (which physicians prescribe what drugs, in what dose, and with what prescribing patterns). Data miners, in turn, lease sophisticated reports to pharmaceutical companies to …